MD Magazine staff

Albert Einstein College of Medicine researchers have developed a new vaccine type that shows promise to possibly become the first ever for preventing genital herpes.

American researchers suggest that households can serve as long-term reservoirs for USA300, a virulent and easily transmissible strain of methicillin-resistant Staphylococus aureus (MRSA) and the predominant community-associated MRSA clone in the United States.